Feed aggregator

Implications of the Emerging SARS-CoV-2 Variant VUI 202012/01

2019 Novel Coronavirus (CDC) - Tue, 12/22/2020 - 07:00
A new variant strain of SARS-CoV-2 that contains a series of mutations has been described in the United Kingdom (UK) and become highly prevalent in London and southeast England.
Categories: C.D.C. (U.S.)

Information about the Pfizer-BioNTech COVID-19 Vaccine

2019 Novel Coronavirus (CDC) - Tue, 12/22/2020 - 07:00
Name: BNT162b2Manufacturer: Pfizer, Inc., and BioNTechType of vaccine: mRNANumber of shots: 2 shots, 21 days apartHow given: Shot in the muscle of the upper arm
Categories: C.D.C. (U.S.)

Communication Toolkit

2019 Novel Coronavirus (CDC) - Tue, 12/22/2020 - 07:00
Translated COVID-19 prevention messages for migrants, refugees, and other limited-English-proficient populations, to reach them in their native languages.
Categories: C.D.C. (U.S.)

Symptoms of Coronavirus

2019 Novel Coronavirus (CDC) - Tue, 12/22/2020 - 07:00
Symptoms
Categories: C.D.C. (U.S.)

New Variant of Virus that Causes COVID-19 Detected

2019 Novel Coronavirus (CDC) - Tue, 12/22/2020 - 07:00
Since November 2020, the United Kingdom (UK) has reported a rapid increase in COVID-19 cases in London and southeast England. This rapid increase in cases has been linked to a different version-or variant-of the virus that causes COVID-19 (SARS-CoV-2).
Categories: C.D.C. (U.S.)

Behavioural considerations for acceptance and uptake of COVID-19 vaccines

WHO news - Mon, 12/21/2020 - 20:34

 

The Behavioural Insights Unit of the WHO released a meeting report of the Technical Advisory Group (TAG) on the special session on acceptance and uptake of COVID-19 vaccines, held on 15 October 2020. The meeting report outlines the factors that drive people’s behaviour in relation to vaccine acceptance and uptake: an enabling environment, social influences and motivation. 

The image above is a visual narration that captures highlights of the meeting on 15 October 2020, during which the TAG on Behavioural Insights and Sciences for Health discussed behavioural considerations in relation to COVID-19 vaccine acceptance and uptake. The discussion was structured around three key questions. Click here to download image in full size.

Download the graphic

 

Joint statement calling for urgent country scale-up of access to optimal HIV treatment for infants and children living with HIV

WHO news - Mon, 12/21/2020 - 20:16
Global partners that are committed to ending paediatric AIDS have come together to call on countries to rapidly scale up access to optimal, child-friendly HIV treatment for infants and children.

First COVID-19 vaccine authorised for use in the European Union

ECDC - News - Mon, 12/21/2020 - 14:00
ECDC welcomes the authorisation of the first vaccine against COVID-19 in EU/EEA. We have been looking forward to this moment for a long time.
On 21 December, EMA recommended granting a conditional marketing authorisation for the vaccine Comirnaty, developed by BioNTech and Pfizer, to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. On the same day, the European Commission has granted market authorisation for EU-wide use.
Categories: C.D.C. (Europe)

Interim SARS-CoV-2 Testing Guidelines for Patients in Outpatient Hemodialysis Facilities

2019 Novel Coronavirus (CDC) - Mon, 12/21/2020 - 07:00
Testing Guidelines for patients undergoing outpatient hemodialysis
Categories: C.D.C. (U.S.)

Participate in Outdoor and Indoor Activities

2019 Novel Coronavirus (CDC) - Mon, 12/21/2020 - 07:00
Lower the likelihood of being exposed to COVID-19 by meeting people who don't live with you outdoors. Read options for indoor and outdoor activities.
Categories: C.D.C. (U.S.)

Cleaning and Disinfecting

2019 Novel Coronavirus (CDC) - Mon, 12/21/2020 - 07:00
Guidance for cleaning and disinfecting a public space, facility, or business to prevent the spread of COVID-19.
Categories: C.D.C. (U.S.)

SARS-CoV-2 Variant – United Kingdom

Disease outbreak news - Mon, 12/21/2020 - 02:00
On 14 December 2020, authorities of the United Kingdom (UK) reported to WHO that a new SARS-CoV-2 variant was identified through viral genomic sequencing. This variant is referred to as SARS-CoV-2 VUI 202012/01 (Variant Under Investigation, year 2020, month 12, variant 01).

Pages

Subscribe to Brain Association Iasi aggregator